Eutilex Rises 7.11% Amid Immune Checkpoint Inhibitor Theme Uptrend

On the 19th, the immuno-oncology theme rose by 4.96% compared to the previous day, showing strong performance, while Eutilex, a related stock attracting attention, surged by 7.11% compared to the previous day.

[Graph] Major Stocks' Fluctuation Rates in the Immuno-Oncology Theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Eutilex's quant financial score was 4.78 points, ranking 19th in quant financial ranking within the immuno-oncology theme. This can be interpreted as Eutilex having relatively low investment attractiveness from a financial perspective. On the other hand, Dong-A ST ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Stocks by Financial Scores within the Theme

※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.